Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 032 7298
Medical Information e-mail: roche@professionalinformation.co.uk
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1748 828801

Patient Information Leaflet last updated on the eMC: 17/01/2012
PIL Loron 520

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/10/2011 and displayed until 17/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 13/06/2008 and displayed until 28/10/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 25/10/2006 and displayed until 13/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 08/09/2006 and displayed until 25/10/2006
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 30/07/2002 and displayed until 08/09/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   disodium clodronate